| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, OR 97201
Coupling of membrane Ig (mIg) and CD40 to the extracellularly regulated kinase (ERK) signal transduction pathway was examined in the WEHI-231 B lymphoma and normal mouse B cells. Cross-linking mIg induces ERK activation in both WEHI-231 and normal B cells. In contrast, CD40 cross-linking failed to induce ERK activation in WEHI-231, but signals through CD40 were more effective than mIg as a stimulus for ERK activation in normal B cells. However, several lines of evidence suggest that CD40 and the B cell Ag regulate ERK through distinct pathways that converge at the level of MEK-1, mitogen-activated protein kinase kinase. Abs to mIg or CD40 induced MEK-1 activation with different kinetics. Cross-linking of mIg, but not CD40, induced tyrosine phosphorylation of the SHC adapter molecule that couples receptors to Ras-dependent signaling pathways. Finally, agents that elevate cAMP, causing protein kinase A-mediated inhibition of Raf-1, inhibited activation of ERK in response to mIg cross-linking, but had no affect on ERK activation in response to anti-CD40 or Jun N-terminal kinase activation by signals through either receptor. Thus, CD40 uses an unidentified protein kinase A-insensitive MEK kinase, rather than Raf-1, to regulate ERK activity.
This article has been cited by other articles:
|
|
 |
|
  H. MacLeod, N. Bhasin, and L. M. Wetzler Role of Protein Tyrosine Kinase and Erk1/2 Activities in the Toll-Like Receptor 2-Induced Cellular Activation of Murine B Cells by Neisserial Porin Clin. Vaccine Immunol., April 1, 2008; 15(4): 630 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O. Nashar and J. R. Drake Dynamics of MHC Class II-Activating Signals in Murine Resting B Cells J. Immunol., January 15, 2006; 176(2): 827 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mizuno and T. L. Rothstein B Cell Receptor (BCR) Cross-Talk: CD40 Engagement Enhances BCR-Induced ERK Activation J. Immunol., March 15, 2005; 174(6): 3369 - 3376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Flaxenburg, M. Melter, P. H. Lapchak, D. M. Briscoe, and S. Pal The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase J. Immunol., June 15, 2004; 172(12): 7503 - 7509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Ha and J. R. Lee Role of TNF Receptor-Associated Factor 3 in the CD40 Signaling by Production of Reactive Oxygen Species through Association with p40phox, a Cytosolic Subunit of Nicotinamide Adenine Dinucleotide Phosphate Oxidase J. Immunol., January 1, 2004; 172(1): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Gauld, D. Blair, C. A. Moss, S. D. Reid, and M. M. Harnett Differential Roles for Extracellularly Regulated Kinase-Mitogen-Activated Protein Kinase in B Cell Antigen Receptor-Induced Apoptosis and CD40-Mediated Rescue of WEHI-231 Immature B Cells J. Immunol., April 15, 2002; 168(8): 3855 - 3864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Wu, C. Venkataraman, S. Estus, C. Dong, R. J. Davis, R. A. Flavell, and S. Bondada Positive Signaling Through CD72 Induces Mitogen-Activated Protein Kinase Activation and Synergizes with B Cell Receptor Signals to Induce X-Linked Immunodeficiency B Cell Proliferation J. Immunol., August 1, 2001; 167(3): 1263 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Richards, S. H. Dave, C.-H. G. Chou, A. A. Mamchak, and A. L. DeFranco Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen J. Immunol., March 15, 2001; 166(6): 3855 - 3864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Pearson, B. E. Castle, and M. R. Kehry CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways Int. Immunol., March 1, 2001; 13(3): 273 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Swart, D. M. Bergeron, and T. C. Chiles Identification of a Membrane Ig-Induced p38 Mitogen-Activated Protein Kinase Module That Regulates cAMP Response Element Binding Protein Phosphorylation and Transcriptional Activation in CH31 B Cell Lymphomas J. Immunol., March 1, 2000; 164(5): 2311 - 2319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shirakata, K. Ishii, H. Yagita, K. Okumura, M. Taniguchi, and T. Takemori Distinct Subcellular Localization and Substrate Specificity of Extracellular Signal-Regulated Kinase in B Cells upon Stimulation with IgM and CD40 J. Immunol., December 15, 1999; 163(12): 6589 - 6597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tan, T. Town, M. Saxe, D. Paris, Y. Wu, and M. Mullan Ligation of Microglial CD40 Results in p44/42 Mitogen-Activated Protein Kinase-Dependent TNF-{alpha} Production That Is Opposed by TGF-{beta}1 and IL-10 J. Immunol., December 15, 1999; 163(12): 6614 - 6621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aicher, G. L. Shu, D. Magaletti, T. Mulvania, A. Pezzutto, A. Craxton, and E. A. Clark Differential Role for p38 Mitogen-Activated Protein Kinase in Regulating CD40-Induced Gene Expression in Dendritic Cells and B Cells J. Immunol., December 1, 1999; 163(11): 5786 - 5795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-L. Li, W. W. Davis, E. L. Whiteman, M. J. Birnbaum, and E. Pure The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes PNAS, June 8, 1999; 96(12): 6890 - 6895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Pullen, T. T. A. Dang, J. J. Crute, and M. R. Kehry CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs). BINDING SITE SPECIFICITY AND ACTIVATION OF DOWNSTREAM PATHWAYS BY DISTINCT TRAFs J. Biol. Chem., May 14, 1999; 274(20): 14246 - 14254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Suttles, D. M. Milhorn, R. W. Miller, J. C. Poe, L. M. Wahl, and R. D. Stout CD40 Signaling of Monocyte Inflammatory Cytokine Synthesis through an ERK1/2-dependent Pathway. A TARGET OF INTERLEUKIN ()-4 AND IL-10 ANTI-INFLAMMATORY ACTION J. Biol. Chem., February 26, 1999; 274(9): 5835 - 5842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li and R. H. Carter Convergence of CD19 and B Cell Antigen Receptor Signals at MEK1 in the ERK2 Activation Cascade J. Immunol., December 1, 1998; 161(11): 5901 - 5908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lee and G. A. Koretzky Extracellular Signal-Regulated Kinase-2, But Not c-Jun NH2-Terminal Kinase, Activation Correlates with Surface IgM-Mediated Apoptosis in the WEHI 231 B Cell Line J. Immunol., August 15, 1998; 161(4): 1637 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tan, T. Town, and M. Mullan CD45 Inhibits CD40L-induced Microglial Activation via Negative Regulation of the Src/p44/42 MAPK Pathway J. Biol. Chem., November 17, 2000; 275(47): 37224 - 37231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Arimura, M. Ogimoto, K. Mitomo, T. Katagiri, K.-i. Yamamoto, S. Volarevic, K. Mizuno, and H. Yakura CD45 Is Required for CD40-induced Inhibition of DNA Synthesis and Regulation of c-Jun NH2-terminal Kinase and p38 in BAL-17 B Cells J. Biol. Chem., March 9, 2001; 276(11): 8550 - 8556. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
